Cagrilintide 10mg × 10 vials

A long-acting amylin analogue studied for weight management research, appetite regulation, metabolic response, satiety signaling, and glucose-related pathways.

Product Overview

Compound: Cagrilintide
Strength: 10 mg per vial
Injection type: Subcutaneous
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 10 mg
BAC water: 2 mL
Amount per unit: 50 mcg per unit

Research Dose

Protocol dependent.

Notes

Cagrilintide is described in published research as a long-acting amylin analogue. It has been studied in weight management and metabolic research, both as a standalone compound and in combination with semaglutide.

No standard consumer dosing protocol should be assumed. Use only within appropriate research or professional guidance frameworks.

Disclaimer

This product is intended for research and informational purposes only.